Scarica l'app Stockscreener
0.2532
10.68%
-0.0311
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cosmos Health Inc Borsa (COSM) Ultime notizie
Cosmos Health (COSM) Reports Strong Q1 2026 Revenue Growth - GuruFocus
Cosmos Health reports Q1 revenue of $17.9M, up 31% year-over-year - Investing.com
Cosmos Health trims $4.5M debt, eyes U.S. nutraceuticals push after record Q1 - Stock Titan
Cosmos Health Inc. 1Q 2026: Revenue $17.93M, EPS ($0.06) — 10-Q Summary - TradingView
Cosmos Health (NASDAQ: COSM) posts Q1 loss and issues going‑concern warning - Stock Titan
Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt P - ACCESS Newswire
Cosmos Health Company Profile & Introduction - Moomoo
COSM Q1'26 Earnings: EPS estimate is (0.01) USD - TradingView
Cosmos Health Inc stock (US22143K1016): volatility after reverse split and uplisting plans draw inve - AD HOC NEWS
Cosmos Health Inc.Common Stock (NQ: COSM - FinancialContent
[NT 10-Q] Cosmos Health Inc. SEC Filing - Stock Titan
Cosmos Health (COSM) Engages European Investment Bank for R&D Fi - GuruFocus
Cosmos Health stock (US22143K1016): Pursues €25M EIB financing for R&D - AD HOC NEWS
Cosmos Health pursues €25M EIB financing for R&D program By Investing.com - Investing.com South Africa
Cosmos Health pursues €25M EIB financing for R&D program - Investing.com
EU bank review could unlock €25M for Cosmos Health drug R&D - Stock Titan
Cosmos Health regains compliance with Nasdaq’s listing rule - MSN
Cosmos Health (COSM) Withdraws Registration Statement for Public Offering - GuruFocus
TradingKey - TradingKey
Cosmos Health stock (US22143K1016): Fort18 launch targets $3.2M revenue boost - AD HOC NEWS
Cosmos Health withdraws SEC registration statement - Investing.com UK
Cosmos Health withdraws SEC registration statement By Investing.com - Investing.com South Africa
Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 - ACCESS Newswire
Cosmos Health scraps public offering, pulls SEC registration - Stock Titan
Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months - Digital Journal
[RW] Cosmos Health Inc. SEC Filing - Stock Titan
Men's stamina supplement Fort18 targets $3.2M U.S. sales - Stock Titan
Cosmos Health Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
COSM introduces new product for sexual health - MSN
Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed - ACCESS Newswire
Cosmos Health(COSM) Stock Options Chain | Quotes & News - Moomoo
Cosmos Health Introduces the "18 Series" in the United StatesA Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products - Quantisnow
COSM Stock Price, Quote & Chart | COSMOS HEALTH INC (NASDAQ:COSM) - ChartMill
Number of shareholders of Cosmos Health Inc. – NASDAQ:COSM - TradingView
Cosmos Health launches Fort18 men’s wellness supplement in U.S. By Investing.com - Investing.com Australia
Cosmos Health launches Fort18 men’s wellness supplement in U.S. - Investing.com UK
Cosmos Health Introduces Fort18 in the United StatesA Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness - ACCESS Newswire
Cosmos Health enters men's wellness as U.S. market heads to $1.93B - Stock Titan
Cosmos Health (COSM) price target increased by 50.00% to 4.59 - MSN
Cosmos Health (COSM) Projects Significant Revenue Growth with Cu - GuruFocus
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):